Suppr超能文献

首次脑卒中后死亡率和复发性血管事件:一项针对 50 万中国成年人的 9 年社区为基础的研究。

Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults.

机构信息

Medical Research Council Population Health Research Unit, Oxford, UK; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

出版信息

Lancet Glob Health. 2020 Apr;8(4):e580-e590. doi: 10.1016/S2214-109X(20)30069-3.

Abstract

BACKGROUND

Stroke is a leading cause of death and disability worldwide. Despite considerable improvements in diagnosis and treatment, little is known about the short-term and long-term prognosis after a first stroke in low-income and middle-income countries, including China. We aimed to assess the short-term and long-term risk of recurrent stroke and mortality after a first stroke for each of the major pathological stroke types.

METHODS

This population-based cohort study included adults aged 35-74 years without disability who were recruited to the China Kadoorie Biobank (CKB). A baseline survey was conducted in ten geographical areas (five urban, five rural) in China, and participants had clinical measurements recorded. Participants were followed up by monitoring death registries and by electronic linkage to health registries and health insurance claims databases, with follow-up until Jan 1, 2017. Participants were excluded from analyses if they had a previous history of stroke, transient ischaemic attack, or ischaemic heart disease at baseline. All incidences of fatal and non-fatal stroke during the study period were recorded by type (ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and unspecified type). Primary outcome measures were 28-day mortality, recurrent stroke, major vascular events (recurrent stroke, myocardial infarction, or vascular death), vascular mortality, and all-cause mortality.

FINDINGS

Of 512 715 individuals in the CKB, 489 586 participants without previous ischaemic heart disease and stroke at recruitment were included, of whom 45 732 (42 073 [92%] confirmed by brain imaging) had a stroke during the study period. The mean age was 59·3 years (SD 9·8) for participants who had a stroke (54% women) and 50·8 years (10·3) for participants with no stroke (60% women). 36 588 (80%) of the incident cases of stroke were ischaemic stroke, 7440 (16%) were intracerebral haemorrhage, 702 (2%) were subarachnoid haemorrhage, and 1002 (2%) were an unspecified stroke type. 28-day mortality was 3% (95% CI 3-4) for ischaemic stroke, 47% (46-48)for intracerebral haemorrhage, 19% (17-22; 52% for rural areas and 32% for urban areas) subarachnoid haemorrhage, and 24% (22-27) for unspecified stroke. Among participants who survived stroke at 28 days, 41% (41-42) had recurrent stroke at 5 years (ischaemic stroke 41% [41-42], intracerebral haemorrhage 44% [42-46], subarachnoid haemorrhage 22% [18-27], unspecified stroke type 40% [35-44]) and mortality at 5 years was 17% ([17-18] ischaemic stroke 16% [15-16], intracerebral haemorrhage 28% [26-29], subarachnoid haemorrhage 16% [12-20], unspecified stroke type 15% [12-19]). After a first ischaemic stroke, 91% of recurrent strokes were also ischaemic stroke; after an intracerebral haemorrhage, 56% of recurrent strokes were intracerebral haemorrhage, and 41% of recurrent strokes were ischaemic stroke.

INTERPRETATION

After a first stroke, the risk of recurrence or death within 5 years was high among this population of Chinese adults. Urgent improvements to secondary prevention of stroke in China are needed to reduce these risks.

FUNDING

Wellcome Trust, Medical Research Council, British Heart Foundation, Cancer Research UK, Kadoorie Charitable Foundation, Chinese Ministry of Science and Technology, National Natural Science Foundation of China.

COPYRIGHT

© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

摘要

背景

卒中是全世界范围内导致死亡和残疾的主要原因之一。尽管在诊断和治疗方面取得了相当大的进展,但对于包括中国在内的低收入和中等收入国家首次卒中后的短期和长期预后,人们知之甚少。我们旨在评估每种主要的病理类型卒中后再次发生卒中的风险和死亡率。

方法

本项基于人群的队列研究纳入了无残疾的 35-74 岁成年人,他们来自中国慢性病前瞻性研究(CKB)。在中国十个地理区域(五个城市,五个农村)进行了基线调查,并记录了参与者的临床测量结果。通过监测死亡登记处以及与健康登记处和健康保险索赔数据库的电子链接对参与者进行随访,随访至 2017 年 1 月 1 日。如果参与者在基线时患有卒中、短暂性脑缺血发作或缺血性心脏病,则将其排除在分析之外。在研究期间,通过类型(缺血性卒中、颅内出血、蛛网膜下腔出血和未指定类型)记录所有致命和非致命性卒中的发生。主要结局指标是 28 天死亡率、再次发生卒中、主要血管事件(再次发生卒中、心肌梗死或血管性死亡)、血管性死亡率和全因死亡率。

结果

在 CKB 的 512715 名参与者中,纳入了 489586 名在招募时没有既往缺血性心脏病和卒中的参与者,其中 45732 名(42073 名[92%]通过脑部成像证实)在研究期间发生了卒中。发生卒中的参与者的平均年龄为 59.3 岁(9.8 岁)(女性占 42%),没有卒中的参与者的平均年龄为 50.8 岁(10.3 岁)(女性占 60%)。36588 例(80%)卒中事件为缺血性卒中,7440 例(16%)为颅内出血,702 例(2%)为蛛网膜下腔出血,1002 例(2%)为未指定的卒中类型。28 天死亡率为缺血性卒中 3%(95%CI 3-4),颅内出血 47%(46-48),蛛网膜下腔出血 19%(17-22;农村地区为 52%,城市地区为 32%),未指定的卒中类型 24%(22-27)。在 28 天存活的卒中患者中,41%(41-42)在 5 年内再次发生卒中(缺血性卒中 41%[41-42],颅内出血 44%[42-46],蛛网膜下腔出血 22%[18-27],未指定的卒中类型 40%[35-44]),5 年死亡率为 17%(17-18)(缺血性卒中 16%[15-16],颅内出血 28%[26-29],蛛网膜下腔出血 16%[12-20],未指定的卒中类型 15%[12-19])。首次发生缺血性卒中后,91%的再次发生卒中为缺血性卒中;首次发生颅内出血后,56%的再次发生卒中为颅内出血,41%的再次发生卒中为缺血性卒中。

解释

在这群中国成年人中,首次卒中后 5 年内再次发生卒中或死亡的风险很高。需要紧急改善中国的卒中二级预防,以降低这些风险。

资金

威康信托基金会、医学研究理事会、英国心脏基金会、英国癌症研究中心、凯度慈善基金会、中国科学技术部、国家自然科学基金委员会。

版权所有

©2020 作者(们)。由 Elsevier Ltd 出版。这是一篇在 CC BY 4.0 许可下的开放获取文章。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3863/7090905/e1188bb59e25/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验